Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

39.70p
   
  • Change Today:
      0.20p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 866,514
  • Market Cap: £214.54m
  • RiskGrade: 119

Alliance Pharma revenues hit by Covid-19 in H1

By Iain Gilbert

Date: Tuesday 21 Jul 2020

LONDON (ShareCast) - (Sharecast News) - Healthcare group Alliance Pharma said on Tuesday that first-half revenues had been impacted by the Covid-19 pandemic, principally in its prescription medicines business.
Alliance said see-through revenues for the first half came to £65.3m, a 7% decrease year-on-year, but noted that based on year-to-date trading, it expects revenue and underlying profit before tax for the full year to be in line with market expectations.

The AIM-listed group's consumer healthcare-focused unit proved "resilient" in the first half, generating sales of £30.0m, but noted that demand for its prescription driven products was lower due to the delays in routine treatments as healthcare professionals focused on maintaining hospital capacity to treat patients with Covid-19.

Alliance also said it experienced only minimal disruption to its supply chain due to Covid-19 and expects to witness further recovery in trading during the second half of the year.

Chief executive Peter Butterfield said: "We expected some reduction in demand during the first half of 2020 as a result of Covid-19. That said, we have come through strongly towards the end of the half and expect trading to recover further as we move into the second half of the year.

"The resilience and diversity of our product portfolio, and the ease with which we have managed to transition the business to operating remotely, position us very well to resume our growth trajectory as the markets for our products recover."

As of 1000 BST, Alliance shares were down 0.39% at 76p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 39.70p
Change Today 0.20p
% Change 0.51 %
52 Week High 71.80
52 Week Low 34.50
Volume 866,514
Shares Issued 540.40m
Market Cap £214.54m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.84% above the market average78.84% above the market average78.84% above the market average78.84% above the market average78.84% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.54% below the market average67.54% below the market average67.54% below the market average67.54% below the market average67.54% below the market average
5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average
Income
10.21% below the market average10.21% below the market average10.21% below the market average10.21% below the market average10.21% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
89.09% below the market average89.09% below the market average89.09% below the market average89.09% below the market average89.09% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 66,726 @ 39.70p
16:35 196 @ 39.70p
16:35 738 @ 39.70p
16:35 62 @ 39.70p
16:35 661 @ 39.70p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page